Kewaunee Scientific Corporation (KEQU)
NASDAQ: KEQUIndustrialsMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
KEQU stock chart
Technical analysisKey statistics
All statistics- Market cap
- $97.14M
- P/E (TTM)
- 12.16
- Forward P/E
- 15.53
- EPS (TTM)
- $2.76
- Dividend yield
- None
- Ex-dividend date
- Sep 9, 2019
- 52-week range
- 32.00 – 43.36
- Day range
- 33.55 – 33.98
- Volume / Avg
- 524 / 4.21K
- Beta
- —
- Shares outstanding
- 2.90M
- Next earnings
- Dec 9, 2026
52-week range
KEQU stock today
On Nov 20, KEQU ended the session at $33.55, shedding $0.95 (2.75%), versus the S&P 500's 3.70% decline. Trading was light, with 524 shares changing hands, about 12% of the average daily volume. At this level, KEQU sits near the bottom of its 52-week range of $32.00 to $43.36: 22.6% below the high, set on Mar 10, 2026 and 4.8% above the low.
KEQU is down 10.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 14.4%. Kewaunee Scientific trades at 12.2x its trailing twelve-month earnings per share of $2.76. Its forward P/E of 15.5x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. The company is scheduled to report Oct/2026 results on Dec 9.
Summary generated from market data by MetaCap's automated system. Methodology
About Kewaunee Scientific
Company profileKewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segments, Lab Products Group (LPG) and International. The company offers steel and wood casework and laboratory cabinetry, fume hoods, adaptable modular and flexible systems, movable workstations, stand-alone and work benches, computer enclosures, biological safety cabinets, CO2 incubators, ultralow freezers, epoxy resin work surfaces and sinks, and other laboratory products.
- Sector
- Industrials
- Industry
- Medical Specialities
- CEO
- Mr. Thomas David Hull III
- Headquarters
- Statesville, NC
- Employees
- 1,231
- Website
- kewaunee.com
Financial highlights
Full financialsIn fiscal 2026, Kewaunee Scientific generated $282.0 million in revenue, up 17.3% from fiscal 2025, its 2nd consecutive year of revenue growth. Net income was $9.6 million (-15.7% year over year), for a net margin of 3.4% versus a median of 0.3% in the prior 5 years. Gross margin was 28.5% (down from 28.6%) and operating margin 5.9%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $282.00M | $240.47M | $203.75M | $219.49M | $168.87M |
| Growth | +17.27% | +18.02% | -7.17% | +29.98% | +14.51% |
| Net income | $9.62M | $11.40M | $18.75M | $738.00K | $-6.13M |
| EPS (diluted) | $3.22 | $3.83 | $6.38 | $0.25 | $-2.20 |
Earnings
Earnings history- Next report
- Dec 9, 2026
- Last reported (Q1 2027)
- Sep 9, 2026
- EPS actual vs est.
- $0.58 vs —
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $0.19
- Ex-dividend date
- Sep 9, 2019
KEQU news
All KEQU newsKewaunee Scientific peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XGNExagen Inc. | 3.61 | -5.00% | $92.10M | vs KEQU |
| BDSXBiodesix Inc. | 7.56 | -8.92% | $83.83M | vs KEQU |
| SERASera Prognostics Inc. Class A | 1.81 | -4.23% | $71.98M | vs KEQU |
| BNRBurning Rock Biotech Limited ADR | 13.24 | -0.60% | $139.63M | vs KEQU |
| TLSITriSalus Life Sciences Inc. | 2.32 | +6.67% | $143.14M | vs KEQU |
| MDXHMDxHealth SA | 0.1074 | -8.52% | $10.25M | vs KEQU |
| AMSAmerican Shared Hospital Services | 1.00 | -4.76% | $6.67M | vs KEQU |
| ACONAclarion Inc. | 1.22 | -13.92% | $3.52M | vs KEQU |
Indexes, lists and sector
Kewaunee Scientific stock FAQ
What is Kewaunee Scientific's stock price today?
KEQU last traded at $33.55 as of Nov 20, 4:00 PM EST, down 2.75% on the day. Prices are delayed at least 15 minutes.
Does Kewaunee Scientific pay a dividend?
Yes. Kewaunee Scientific pays $0.00 per share annually. The most recent dividend of $0.19 had an ex-dividend date of Sep 9, 2019.
When is Kewaunee Scientific's next earnings date?
Kewaunee Scientific is expected to report earnings on Wednesday, December 9, 2026.
What is KEQU's P/E ratio?
KEQU trades at a trailing P/E ratio of 12.16 and a forward P/E of 15.53.
Who is Kewaunee Scientific's CEO?
Mr. Thomas David Hull III is the chief executive officer of Kewaunee Scientific Corporation, which has about 1,231 employees.
Has KEQU ever split its stock?
Yes. The most recent KEQU stock split was a 3-for-2 split on Jan 7, 1985, one of 2 splits on record.
What is the KEQU 52-week high?
The 52-week high for KEQU is $43.36 and the 52-week low is $32.00. The stock is currently 22.6% below its high.